Cargando…

Tumor copy number alteration burden is a pan-cancer prognostic factor associated with recurrence and death

The level of copy number alteration (CNA), termed CNA burden, in the tumor genome is associated with recurrence of primary prostate cancer. Whether CNA burden is associated with prostate cancer survival or outcomes in other cancers is unknown. We analyzed the CNA landscape of conservatively treated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hieronymus, Haley, Murali, Rajmohan, Tin, Amy, Yadav, Kamlesh, Abida, Wassim, Moller, Henrik, Berney, Daniel, Scher, Howard, Carver, Brett, Scardino, Peter, Schultz, Nikolaus, Taylor, Barry, Vickers, Andrew, Cuzick, Jack, Sawyers, Charles L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	eLife Sciences Publications, Ltd 2018
Materias:	Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6145837/ https://www.ncbi.nlm.nih.gov/pubmed/30178746 http://dx.doi.org/10.7554/eLife.37294

Ejemplares similares

Deletion of 3p13-14 locus spanning FOXP1 to SHQ1 cooperates with PTEN loss in prostate oncogenesis
por: Hieronymus, Haley, et al.
Publicado: (2017)

Prognostic value of Ki-67 for prostate cancer death in a conservatively managed cohort
por: Fisher, G, et al.
Publicado: (2013)

Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer
por: Shah, Neel, et al.
Publicado: (2017)

Modulators of Prostate Cancer Cell Proliferation and Viability Identified by Short-Hairpin RNA Library Screening
por: Dahlman, Kimberly Brown, et al.
Publicado: (2012)

The percentage of high‐grade prostatic adenocarcinoma in prostate biopsies significantly improves on Grade Groups in the prediction of prostate cancer death
por: Berney, Daniel M, et al.
Publicado: (2019)

Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome
por: Berney, Daniel M, et al.
Publicado: (2016)

Prognostic and immunological role of Fam20C in pan-cancer
por: Liu, Xinpeng, et al.
Publicado: (2021)

Comprehensive analysis of DTYMK in pan-cancer and verification in lung adenocarcinoma
por: Zhang, Yue, et al.
Publicado: (2022)

MYC Cooperates with AKT in Prostate Tumorigenesis and Alters Sensitivity to mTOR Inhibitors
por: Clegg, Nicola J., et al.
Publicado: (2011)

Validation of the cell cycle progression score to differentiate indolent from aggressive prostate cancer in men diagnosed through transurethral resection of the prostate biopsy
por: Cuzick, Jack M., et al.
Publicado: (2021)

Long-term outcome among men with conservatively treated localised prostate cancer
por: Cuzick, J, et al.
Publicado: (2006)

Challenges in validating candidate therapeutic targets in cancer
por: Settleman, Jeffrey, et al.
Publicado: (2018)

Should reporting of peri-neural invasion and extra prostatic extension be mandatory in prostate cancer biopsies? correlation with outcome in biopsy cases treated conservatively
por: Ahmad, Amar S., et al.
Publicado: (2018)

Feasibility study of a clinically-integrated randomized trial of modifications to radical prostatectomy
por: Vickers, Andrew J, et al.
Publicado: (2012)

The panoramic picture of pepsinogen gene family with pan‐cancer
por: Shen, Shixuan, et al.
Publicado: (2020)

Prognostic and immune regulating roles of YIF1B in Pan-Cancer: a potential target for both survival and therapy response evaluation
por: Liu, Jun, et al.
Publicado: (2020)

Copy-number and gene dependency analysis reveals partial copy loss of wild-type SF3B1 as a novel cancer vulnerability
por: Paolella, Brenton R, et al.
Publicado: (2017)

Conservatism and “copy-if-better” in chimpanzees (Pan troglodytes)
por: van Leeuwen, Edwin J. C., et al.
Publicado: (2016)

Mitochondrial respiratory gene expression is suppressed in many cancers
por: Reznik, Ed, et al.
Publicado: (2017)

Mir143 expression inversely correlates with nuclear ERK5 immunoreactivity in clinical prostate cancer
por: Ahmad, I, et al.
Publicado: (2013)

Pan-cancer association of DNA repair deficiencies with whole-genome mutational patterns
por: Sørensen, Simon Grund, et al.
Publicado: (2023)

Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study
por: Berney, D M, et al.
Publicado: (2009)

Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort
por: Cuzick, J, et al.
Publicado: (2012)

Systematic identification of mutations and copy number alterations associated with cancer patient prognosis
por: Smith, Joan C, et al.
Publicado: (2018)

Pan-cancer patterns of somatic copy-number alteration
por: Zack, Travis I., et al.
Publicado: (2013)

Expression of SNAIL in accompanying PanIN is a key prognostic indicator in pancreatic ductal adenocarcinomas
por: Fujiwara, Sho, et al.
Publicado: (2019)

Pan-cancer analysis of non-coding recurrent mutations and their possible involvement in cancer pathogenesis
por: Kikutake, Chie, et al.
Publicado: (2021)

Hsp-27 expression at diagnosis predicts poor clinical outcome in prostate cancer independent of ETS-gene rearrangement
por: Foster, C S, et al.
Publicado: (2009)

Prognostic value of PTEN loss in men with conservatively managed localised prostate cancer
por: Cuzick, J, et al.
Publicado: (2013)

Copy number alterations in urothelial carcinomas: their clinicopathological significance and correlation with DNA methylation alterations
por: Nishiyama, Naotaka, et al.
Publicado: (2011)

Establishment of tumor-specific copy number alterations from plasma DNA of patients with cancer
por: Heitzer, Ellen, et al.
Publicado: (2013)

The clinically-integrated randomized trial: proposed novel method for conducting large trials at low cost
por: Vickers, Andrew J, et al.
Publicado: (2009)

The aberrant expression of rhythm genes affects the genome instability and regulates the cancer immunity in pan‐cancer
por: Zhou, Jian, et al.
Publicado: (2020)

Validation of an RNA cell cycle progression score for predicting death from prostate cancer in a conservatively managed needle biopsy cohort
por: Cuzick, J, et al.
Publicado: (2015)

GREB1 amplifies androgen receptor output in human prostate cancer and contributes to antiandrogen resistance
por: Lee, Eugine, et al.
Publicado: (2019)

Robust genomic copy number predictor of pan cancer metastasis
por: Pearlman, Alexander, et al.
Publicado: (2018)

Characterizing HDAC Pathway Copy Number Variation in Pan-Cancer
por: Yang, Shuming, et al.
Publicado: (2022)

Mitochondrial DNA copy number is associated with risk of head and neck squamous cell carcinoma in Chinese population
por: Wang, Lihua, et al.
Publicado: (2018)

Novel insights into breast cancer copy number genetic heterogeneity revealed by single-cell genome sequencing
por: Baslan, Timour, et al.
Publicado: (2020)

Co-evolution of AR gene copy number and structural complexity in endocrine therapy resistant prostate cancer
por: Zivanovic, Andrej, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5um2ecmj19p2m19s7vrofkmev7